Search - tctmd.com

Displaying 101 - 120 of 2097

Sort: Relevancy | Date

News Features

What’s in a Name: Is It Time to Choose Between TAVI and TAVR?

Yael L. Maxwell

March 27, 2025

News Daily News

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Michael O'Riordan

March 26, 2025

News Conference News CRT 2025

ATTENUATE: Protective Drape Cuts Operator Radiation Dose Across Interventions

L.A. McKeown

March 14, 2025

News Daily News

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

Michael O'Riordan

March 13, 2025

Genetic Risk Score for Endothelial Cell Dysfunction Identifies Patients at Risk

News Daily News

Genetic Risk Score for Endothelial Cell Dysfunction May Help Hone ASCVD Care

Michael O'Riordan

February 27, 2025

News Daily News

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Michael O'Riordan

February 24, 2025

News Conference News THT 2025

Positive Results With Carillon Mitral Device Seen in Real-world Registries

Todd Neale

February 21, 2025

Podcast TCTMD Talking Points

The ORBITA-COSMIC Trial

February 12, 2025

News Daily News

AHA Stats Show CV Health of Americans Remains Dire

Michael O'Riordan

January 28, 2025

News Daily News

High BP While Lying Down Signals Future CVD Risk

Todd Neale

January 22, 2025

News Industry News

Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States

January 21, 2025

News Daily News

Higher Lp(a) Indicates Greater Chance of Stenosis on CCTA in Patients With Chest Pain

Yael L. Maxwell

January 13, 2025

News Daily News

Immediate Angiography in OHCA Without STEMI Could Harm: TOMAHAWK and COACT

Caitlin E. Cox

December 27, 2024

News Daily News

PREVENT Tool Accurately Predicts HF Risk, With ‘Strong’ ASCVD Overlap

Yael L. Maxwell

December 17, 2024

News Daily News

Young Men Who Take Steroids Have Impaired Coronary Flow, Even After Quitting

Caitlin E. Cox

December 17, 2024

News Daily News

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

L.A. McKeown

December 12, 2024

News Conference News PCR London Valves 2024

Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP

Michael O'Riordan

December 05, 2024

News Conference News TCT 2024

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

Caitlin E. Cox

October 30, 2024

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Todd Neale

October 30, 2024

Presentation TCT 2024

Transcatheter Forward-Shifted IVL for Uncrossable Coronary Lesions: First-in-Human Experience

Presenter: Julian Strange

October 30, 2024

Advertisement

What’s in a Name: Is It Time to Choose Between TAVI and TAVR?

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

ATTENUATE: Protective Drape Cuts Operator Radiation Dose Across Interventions

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

Genetic Risk Score for Endothelial Cell Dysfunction May Help Hone ASCVD Care

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Positive Results With Carillon Mitral Device Seen in Real-world Registries

The ORBITA-COSMIC Trial

AHA Stats Show CV Health of Americans Remains Dire

High BP While Lying Down Signals Future CVD Risk

Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States

Higher Lp(a) Indicates Greater Chance of Stenosis on CCTA in Patients With Chest Pain

Immediate Angiography in OHCA Without STEMI Could Harm: TOMAHAWK and COACT

PREVENT Tool Accurately Predicts HF Risk, With ‘Strong’ ASCVD Overlap

Young Men Who Take Steroids Have Impaired Coronary Flow, Even After Quitting

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Transcatheter Forward-Shifted IVL for Uncrossable Coronary Lesions: First-in-Human Experience

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content